raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:280553

Fatal infantile hypertonic myofibrillar myopathy

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Infancy, Neonatal
Status
active

Fatal infantile hypertonic myofibrillar myopathy is a rare, genetic skeletal muscle disease characterized by muscle stiffness and rigidity, hypertonia, weakness, respiratory distress and normal cognition. Patients have persistently elevated creatine kinase and histopathology is typical of myofibrillar myopathy. The manifestation onset follows the short period of normal infantile development and leads to progressive respiratory insufficiency and early death.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFatal infantile hypertonic myofibrillar myopathy
frMyopathie myofibrillaire hypertonique infantile fatale
deFatale infantile hypertone myofibrilläre Myopathie
esMiopatía miofibrilar hipertónica letal del lactanteMiopatía miofibrilar ligada al alfa-B-cristalina
itMiopatia miofibrillare ipertonica infantile fatale
nlFatale infantiele hypertonische myofibrillaire myopathie
ptMiopatia miofibrilar hipertónica fatal, do latenteMiopatia miofibrilar relacionada com cristalino alfa-B
plŚmiertelna dziecięca miopatia miofibrylarna ze wzmożonym napięciem
csFatální infantilní hypertonická myofibrilární myopatie
ukФатальна дитяча гіпертонічна міофібрилярна міопатія
zh致死性婴儿高肌张力性肌原纤维肌病
trFatal infantil hipertonik miyofibriler miyopati

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM613869Evalidated
ICD-10G71.2NTBTattributedvalidated
ICD-118C76NTBTindexvalidated
MONDO0013472Evalidated
UMLSC5190691Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CRYABDisease-causing germline mutation(s) inAssessedHGNC:2389ENSG0000010984612359011q23.1crystallin alpha B21337604[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families11 casesWorldwideCase(s)Validated21337604[PMID]_22734908[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_21337604[PMID]_22734908[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card